Wipro GE Healthcare Launches AI Enabled Ultrasound System

05 Mar 2025 CW Team

India’s 1.4Bn population, and a burgeoning NCD problem, underline the need for advanced technologies to enable precise diagnosis, improve clinical accuracy, and reduce the administrative burden. An extension of the Versana ultrasound range, Versana Premier R3 integrates artificial intelligence and offers automation and AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy. The advanced ultrasound system aims to help clinicians deliver more personalized, ubiquitous, and preventive care. Addressing the skill gap, the system will optimise dynamic tissue imaging, assist with volume calculations, and streamline workflows. Its self-learning onboarding tool will empower the clinicians to enhance their skills and adapt to new workflows.

Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia said, “At Wipro GE Healthcare we continue to make advancements in AI, investing in foundation models that can help enhance precision care, ease clinical workflows and enable better patient outcomes. AI is central to building a future where healthcare is personalized, preventive, and affordable. The launch of our Versana Premier R3, is yet another testament to our commitment towards the delivery of ‘Made in India MedTech – for India and the world.”

Anup Kumar, Business Head, Ultrasound, Wipro GE Healthcare added, “We are very proud to launch the Versana Premier R3, our state-of-the-art our ‘Made in India’ ultrasound system. With the growing NCD burden in the country, there is a pressing need for advanced patient centric technologies that can provide faster, personalized, and more accurate diagnosis. Powered by AI, Versana Premier R3 delivers exceptional image clarity, and versatile organ scanning, enhancing diagnostic precision, and empowering clinicians to make timely and well-informed decisions.”

A rzcent report by PwC indicates that 57% of healthcare providers in India are using AI, significantly higher than the adoption rates globally. As India embraces the potential of artificial intelligence in healthcare, Versana Premier R3 represents a significant leap in diagnostic capabilities. The product’s cutting-edge ‘VisionBoost architecture’ and 8-million-channel digital processing deliver exceptional image clarity. With compatibility for 23 different probes, the system offers dynamic organ scanning.

Wipro GE Healthcare has been pioneering ‘Make in India – for India and the world’ for decades. Other Made in India products from the company’s PLI factory include the Revolution Aspire CT system and Optima IGS320 AI-enabled Cath Lab, among others. Earlier this year, Wipro GE Healthcare also announced an investment of over INR8000 Crores in manufacturing output & local R&D over the next 5 years.

Wipro GE Healthcare, a leading global provider of healthcare technologies, announced the launch of the Versana Premier R3, an advanced AI-enabled ultrasound system designed to enhance clinical efficiency and accuracy, streamline workflows, and improve patient outcomes. Catapulting Government’s ‘Make in India’ vision, the state-of-the-art ultrasound system will be manufactured at Wipro GE Healthcare’s PLI factory in Bengaluru. India’s 1.4Bn population, and a burgeoning NCD problem, underline the need for advanced technologies to enable precise diagnosis, improve clinical accuracy, and reduce the administrative burden. An extension of the Versana ultrasound range, Versana Premier R3 integrates artificial intelligence and offers automation and AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy. The advanced ultrasound system aims to help clinicians deliver more personalized, ubiquitous, and preventive care. Addressing the skill gap, the system will optimise dynamic tissue imaging, assist with volume calculations, and streamline workflows. Its self-learning onboarding tool will empower the clinicians to enhance their skills and adapt to new workflows. Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia said, “At Wipro GE Healthcare we continue to make advancements in AI, investing in foundation models that can help enhance precision care, ease clinical workflows and enable better patient outcomes. AI is central to building a future where healthcare is personalized, preventive, and affordable. The launch of our Versana Premier R3, is yet another testament to our commitment towards the delivery of ‘Made in India MedTech – for India and the world.” Anup Kumar, Business Head, Ultrasound, Wipro GE Healthcare added, “We are very proud to launch the Versana Premier R3, our state-of-the-art our ‘Made in India’ ultrasound system. With the growing NCD burden in the country, there is a pressing need for advanced patient centric technologies that can provide faster, personalized, and more accurate diagnosis. Powered by AI, Versana Premier R3 delivers exceptional image clarity, and versatile organ scanning, enhancing diagnostic precision, and empowering clinicians to make timely and well-informed decisions.” A rzcent report by PwC indicates that 57% of healthcare providers in India are using AI, significantly higher than the adoption rates globally. As India embraces the potential of artificial intelligence in healthcare, Versana Premier R3 represents a significant leap in diagnostic capabilities. The product’s cutting-edge ‘VisionBoost architecture’ and 8-million-channel digital processing deliver exceptional image clarity. With compatibility for 23 different probes, the system offers dynamic organ scanning. Wipro GE Healthcare has been pioneering ‘Make in India – for India and the world’ for decades. Other Made in India products from the company’s PLI factory include the Revolution Aspire CT system and Optima IGS320 AI-enabled Cath Lab, among others. Earlier this year, Wipro GE Healthcare also announced an investment of over INR8000 Crores in manufacturing output & local R&D over the next 5 years.

Infrastructure Transport

06 Feb 2026

Lucknow Metro East-West Corridor Consultancy Contract Awarded

The Uttar Pradesh Metro Rail Corporation has awarded the first construction-related consultancy contract for the Lucknow Metro East West Corridor to a joint venture of AYESA Ingenieria Arquitectura SAU and AYESA India Pvt Ltd. The firm was declared the lowest bidder for the Detailed Design Consultant contract for Lucknow Metro Line-2 under Phase 1B and the contract was recommended following the financial bid. The contract is valued at Rs 159.0 million (mn), covering design services for the corridor. Lucknow Metro Line-2 envisages the construction of an 11.165 kilometre corridor connecting Cha..

Infrastructure Urban

06 Feb 2026

Div Com Kashmir Urges Fast Tracking Of Jhelum Water Transport Project

The Divisional Commissioner of Kashmir has called for the fast-tracking of the Jhelum water transport project, urging district administrations and relevant agencies to accelerate planning and clearances. In a meeting convened at the divisional headquarters, the commissioner instructed officials from irrigation, public health engineering and municipal departments to prioritise the project and coordinate survey and design work. The directive emphasised removal of administrative bottlenecks and close monitoring to ensure timely mobilisation of resources and contractors. Officials were told to in..

Infrastructure Urban

06 Feb 2026

Interarch Reports Strong Q3 And Nine Month Results

Interarch Building Solutions Limited reported unaudited results for the third quarter and nine months ended 31 December 2025, recording strong revenue growth driven by execution and a robust order book. Net revenue for the third quarter rose by 43.7 per cent to Rs 5.225 billion (bn), compared with Rs 3.636 bn a year earlier, reflecting heightened demand in pre-engineered building projects. The company’s total order book as at 31 January 2026 stood at Rs 16.85 bn, supporting near-term visibility. EBITDA excluding other income for the quarter increased by 43.2 per cent to Rs 503 million (mn),..